Lux, M. P., Reichelt, C., Karnon, J., Tänzer, T. D., Radosavac, D., Fasching, P. A., . . . Thiel, F. C. (2011). Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System. S. Karger GmbH.

Lux, Michael P., Claudia Reichelt, Jon Karnon, Thorsten D. Tänzer, Dragan Radosavac, Peter A. Fasching, Matthias W. Beckmann, e Falk C. Thiel. Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients With Hormone Receptor-Positive Breast Cancer, Based On Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System. S. Karger GmbH, 2011.

Lux, Michael P., et al. Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients With Hormone Receptor-Positive Breast Cancer, Based On Survival Data and Future Prices for Generic Drugs in the Context of the German Health Care System. S. Karger GmbH, 2011.